Literature DB >> 17499583

Summing the risk of NSAID therapy.

James M Scheiman1, A Mark Fendrick.   

Abstract

Mesh：

Substances：

Year:  2007        PMID： 17499583     DOI： 10.1016/S0140-6736(07)60722-3

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  22 in total

Review 1.  Proton pump inhibitors: an update of their clinical use and pharmacokinetics.

Authors:  Shaojun Shi; Ulrich Klotz
Journal:  Eur J Clin Pharmacol       Date:  2008-08-05       Impact factor: 2.953

2.  Comparison between 3-Nitrooxyphenyl acetylsalicylate (NO-ASA) and O2-(acetylsalicyloxymethyl)-1-(pyrrolidin-1-yl)diazen-1-ium-1,2-diolate (NONO-ASA) as safe anti-inflammatory, analgesic, antipyretic, antioxidant prodrugs.

Authors:  Mitali Chattopadhyay; Carlos A Velazquez; April Pruski; Kamran V Nia; Khaled R Abdellatif; Larry K Keefer; Khosrow Kashfi
Journal:  J Pharmacol Exp Ther       Date:  2010-08-02       Impact factor: 4.030

3.  Prevention of chemically induced urinary bladder cancers by naproxen: protocols to reduce gastric toxicity in humans do not alter preventive efficacy.

Authors:  Ronald A Lubet; James M Scheiman; Ann Bode; Jonathan White; Lori Minasian; M Margaret Juliana; Daniel L Boring; Vernon E Steele; Clinton J Grubbs
Journal:  Cancer Prev Res (Phila)       Date:  2015-03-11

Review 4.  Celecoxib: a review of its use in the management of arthritis and acute pain.

Authors:  James E Frampton; Gillian M Keating
Journal:  Drugs       Date:  2007       Impact factor: 9.546

5.  Education-based approach to addressing non-evidence-based practice in preventing NSAID-associated gastrointestinal complications.

Authors:  Angel Lanas; Juan-V Esplugues; Javier Zapardiel; Eduardo Sobreviela
Journal:  World J Gastroenterol       Date:  2009-12-21       Impact factor: 5.742

6.  Esomeprazole for the management of upper gastrointestinal symptoms in patients who require NSAIDs: a review of the NASA and SPACE double-blind, placebo-controlled studies.

Authors:  Christopher J Hawkey; Lars-Erik Svedberg; Jørgen Naesdal; Claire Byrne
Journal:  Clin Drug Investig       Date:  2009       Impact factor: 2.859

Review 7.  Comparison of gastrointestinal adverse effects between cyclooxygenase-2 inhibitors and non-selective, non-steroidal anti-inflammatory drugs plus proton pump inhibitors: a systematic review and meta-analysis.

Authors:  Saharat Jarupongprapa; Prapassorn Ussavasodhi; Wanruchada Katchamart
Journal:  J Gastroenterol       Date:  2012-12-04       Impact factor: 7.527

8.  [Conservative therapy of osteoarthritis].

Authors:  P Diehl; L Gerdesmeyer; J Schauwecker; P C Kreuz; H Gollwitzer; T Tischer
Journal:  Orthopade       Date:  2013-02       Impact factor: 1.087

9.  Positional isomers of aspirin are equally potent in inhibiting colon cancer cell growth: differences in mode of cyclooxygenase inhibition.

Authors:  Ravinder Kodela; Mitali Chattopadhyay; Satindra Goswami; Zong Yuan Gan; Praveen P N Rao; Kamran V Nia; Carlos A Velázquez-Martínez; Khosrow Kashfi
Journal:  J Pharmacol Exp Ther       Date:  2013-01-24       Impact factor: 4.030

10.  Aspirin-induced mucosal cell death in human gastric cells: role of a caspase-independent mechanism.

Authors:  Anna M Leung; Maria J Redlak; Thomas A Miller
Journal:  Dig Dis Sci       Date:  2008-07-09       Impact factor: 3.199
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.